These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1208 related articles for article (PubMed ID: 3866512)

  • 1. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
    Fujimoto S; Inagaki J; Horikoshi N; Ogawa M
    Gan; 1979 Aug; 70(4):411-20. PubMed ID: 92432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacies of aclacinomycin A by oral administration.
    Tsukagoshi S; Tsuruo T; Yamori T; Iida H; Naganuma K; Sakurai Y
    J Pharmacobiodyn; 1980 Oct; 3(10):532-6. PubMed ID: 6937651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
    Goldin A; Venditti JM; Geran R
    Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental antimetastatic activity of aclarubicin].
    Viadro MM; Terent'eva TG
    Antibiot Khimioter; 1988 Nov; 33(11):845-8. PubMed ID: 3228327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
    Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin.
    Neil GL; Kuentzel SL; McGovren JP
    Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
    Warrell RP; Kempin SJ
    Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antitumor activity of liposomal aclarubicin in vitro and in vivo].
    Viadro MM; Navashin SM
    Biull Eksp Biol Med; 1991 Nov; 112(11):523-5. PubMed ID: 1810495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.